Kristin Hodous | Senior Manager, IR |
Jeffrey Albers | CEO, President & Director |
Christina Rossi | Chief Commercial Officer |
Michael Landsittel | CFO |
Anthony Boral | Chief Medical Officer |
Salveen Richter | Goldman Sachs Group |
Charles Zhu | Guggenheim |
Marc Frahm | Cowen and Company |
David Lebowitz | Morgan Stanley |
Andrew Berens | SVB Leerink |
Michael Ulz | Robert W. Baird & Co. |
Arlinda Lee | Canaccord Genuity Corp. |
David Nierengarten | Wedbush Securities |
Good day, ladies and gentlemen, and welcome to the Q2 2019 Blueprint Medicines Corp Conference Call. [Operator Instructions]. I would now like to introduce your host for today's conference, Kristin Hodous of Blueprint Medicines. Ma'am, you may begin.
Thank you, Operator.